Guangdong Zhongsheng Pharmaceutical Co., Ltd.

Shenzhen Stock Exchange 002317.SZ

Guangdong Zhongsheng Pharmaceutical Co., Ltd. Free Cash Flow for the year ending December 31, 2023: USD -24.29 M

Guangdong Zhongsheng Pharmaceutical Co., Ltd. Free Cash Flow is USD -24.29 M for the year ending December 31, 2023, a 18.20% change year over year. Free cash flow is the amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.

Guangdong Zhongsheng Pharmaceutical Co., Ltd. Free Cash Flow for the year ending December 31, 2022 was USD -29.69 M, a -146.13% change year over year.
Guangdong Zhongsheng Pharmaceutical Co., Ltd. Free Cash Flow for the year ending December 31, 2021 was USD 64.37 M, a 2,810.35% change year over year.
Guangdong Zhongsheng Pharmaceutical Co., Ltd. Free Cash Flow for the year ending December 31, 2020 was USD -2.37 M, a -113.47% change year over year.
Guangdong Zhongsheng Pharmaceutical Co., Ltd. Free Cash Flow for the year ending December 31, 2019 was USD 17.64 M, a -33.82% change year over year.

Key data

Date	Free Cash Flow	Operating Cash Flow	Net Cash Used For Investing Activities	Net Cash Used Provided By Financing Activities

Shenzhen Stock Exchange: 002317.SZ

Guangdong Zhongsheng Pharmaceutical Co., Ltd.

CEO	Mr. Yong Hong Chen
IPO Date	Dec. 11, 2009
Location	China
Headquarters	Information Industry Park
Employees	1,732
Sector	Health Care
Industries Pharmaceuticals

Description

Guangdong Zhongsheng Pharmaceutical Co., Ltd. researches, develops, produces, and sells pharmaceutical products in China. The company offers Chinese and chemical medicines. It is also involved in the research and development of products in the fields of ophthalmology, cardiovascular, cerebrovascular, respiratory, digestive, diabetes, tumor, and senile degenerative diseases. The company was founded in 1979 and is based in Dongguan, China.

Key trends

Past 5 years